stars 1 stars 2 stars 3

At Kinzbio, we develop phage-based therapies and preventive solutions to treat bacterial infections in humans, particularly those caused by antibiotic-resistant bacteria. Our platform enables us to deliver high-quality, personalized therapies within 5–15 days, tailored to the specific bacterium causing the patient’s infection

Kinzbio Questions

Gregorio Iraola is the CEO of Kinzbio.

10 people are employed at Kinzbio.

Kinzbio is based in Montevideo, Montevideo Department.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users